• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱切除术:是膀胱原位癌患者的首选治疗方法吗?

Cystectomy: the treatment of choice in patients with carcinoma in situ of the urinary bladder?

作者信息

Jakse G, Putz A, Feichtinger J

机构信息

Department of Urology, University of Innsbruck, Austria.

出版信息

Eur J Surg Oncol. 1989 Jun;15(3):211-6.

PMID:2737308
Abstract

Patients (n = 46) with carcinoma in situ (Tis) of the urinary bladder were treated by intravesical chemotherapy. The complete remission rate was 75%. After a mean interval of 17 months recurrent tumours were diagnosed in 47%. Radical cystectomy with urethrectomy was performed in eight patients. Distal ureterectomy and uretercystoneostomy was done in six patients because of a distal ureteric tumour. Based on this group of 46 patients and the current literature, the following criteria are essential in indicating cystectomy: (1) micro-invasion; (2) persistent Tis after adequate intravesical treatment; (3) progressive tumour; (4) Tis of ureter and/or prostate; (5) tumour recurrence at more advanced stage.

摘要

46例膀胱原位癌(Tis)患者接受了膀胱内化疗。完全缓解率为75%。平均间隔17个月后,47%的患者被诊断出肿瘤复发。8例患者接受了根治性膀胱切除术加尿道切除术。6例患者因输尿管远端肿瘤行远端输尿管切除术和输尿管膀胱吻合术。基于这组46例患者及当前文献,以下标准对于指示膀胱切除术至关重要:(1)微浸润;(2)充分膀胱内治疗后Tis持续存在;(3)肿瘤进展;(4)输尿管和/或前列腺Tis;(5)更晚期的肿瘤复发。

相似文献

1
Cystectomy: the treatment of choice in patients with carcinoma in situ of the urinary bladder?膀胱切除术:是膀胱原位癌患者的首选治疗方法吗?
Eur J Surg Oncol. 1989 Jun;15(3):211-6.
2
Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.局部膀胱热疗联合膀胱内化疗治疗高级别浅表性膀胱癌。
Urology. 2004 Mar;63(3):466-71. doi: 10.1016/j.urology.2003.10.036.
3
Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.浅表性膀胱肿瘤患者的临床全尿路上皮疾病:治疗意义。
J Urol. 2002 May;167(5):2007-11.
4
[T1 G3 bladder tumors: the respective role of BCG and cystectomy].
Prog Urol. 1995 Apr;5(2):231-7.
5
The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.复发性高危浅表性膀胱肿瘤患者根治性膀胱切除术的最佳时机。
BJU Int. 2004 Dec;94(9):1258-62. doi: 10.1111/j.1464-410X.2004.05228.x.
6
[Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy].[辅助化疗治疗膀胱pT3b浸润性肿瘤的预后]
Prog Urol. 1998 Dec;8(6):1007-11.
7
Small cell carcinoma of the urinary bladder. The Mayo Clinic experience.膀胱小细胞癌。梅奥诊所的经验。
Cancer. 2005 Mar 15;103(6):1172-8. doi: 10.1002/cncr.20903.
8
Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.高危浅表性膀胱肿瘤患者膀胱内卡介苗治疗失败后的膀胱切除术:术前前列腺受累作为一个预后因素。
Eur Urol. 2005 Jul;48(1):53-9; discussion 59. doi: 10.1016/j.eururo.2005.03.021. Epub 2005 Apr 7.
9
[Treatment of PT1 tumors of the bladder using transurethral resection and intravesical immunotherapy].[经尿道切除术联合膀胱内免疫疗法治疗膀胱PT1肿瘤]
Ann Urol (Paris). 1990;24(2):97-101; discussion 102.
10
[Treatment of stage Ta,T1 and Tis bladder tumors using Calmette-Guérin bacillus vaccine].[使用卡介苗疫苗治疗Ta、T1期和Tis期膀胱肿瘤]
Prog Urol. 1993 Aug-Sep;3(4):608-17.